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chest X-Dear Editor,
We read with great pleasure the recent article wrote by Toker
et al in your esteemed journal.1 We would like to share our experi-
ence of two similar cases on “Role of ascorbic acid in treating
methemoglobinemia”.
A-45 year oldmiddle aged gentlemanwas diagnosed as a case of
acute ITP 6 months back when he was evaluated for symptoms of
epistaxis and melena. He was treated with pulse doses of methyl-
prednisolone (1000 mg for 3 days) followed by oral steroid therapy
(1 mg/kg). He responded dramatically with complete resolution of
symptoms and recovery of platelet count. Later, steroids were
tapered on follow up and he became drug free. Three months after
completion of therapy, he relapsed with complaints of gum bleed
and petechial spots all over the body. Laboratory evaluation
revealed severe thrombocytopenia (6  106/L). In view of his past
treatment history and good response to steroid therapy, he was
again started on oral steroid therapy (1 mg/kg). However, unlike
the previous episode there was a stunted response to steroids
this time and hence alternative medications were considered.
Due to ﬁnancial constraints, costlier immunosuppressive agents
like azathioprine, mycophenolate, cyclosporine, immunoglobulins
or rituximab could not be considered in this case. In view of poor
ﬁnances and a normal G6PD status, he was started on Dapsone
(300 mg/day) as a cheaper and possibly an effective alternative
along with anti-ﬁbrinolytic agents and platelet transfusions. Three
days after starting Dapsone, patient complained of mild dyspnea on
exertion. On examination, he was sitting comfortably with a RR of
22/min, with mild tachycardia (88/min) & subtle peripheral
cyanosis. Pulse oximetry showed a decreased SpO2 of 88% at
room air. At the same time, arterial blood gas (ABG) analysisr to editor is being sent e
ch treatment is best? Toker I1,
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ons.org/licenses/by-nc-nd/4.0/).O2 saturation of 99.5%. Chest auscultation ﬁndings and
ray were normal. As the patient received tablet Dapsone
for 3 days and there was mismatch of SpO2 in ABG and pulse oxim-
etery, possibility of Dapsone induced methemoglobinemia was
kept. Co-oximetery showed MetHb level of 18.3%. Immediately,
Dapsone was stopped and high ﬂow O2 inhalation was started.
Due to unavailability of methylene blue, patient was treated with
intravenous infusion of vitamin C (dose of 2 g/day). The mismatch
of SpO2 gradually improved, 4 days later SpO2 by pulse oximetry
was 98% at room air and 97.5% in ABG thereby suggesting resolution
of acute insult. MetHb level was repeated on day 4 and day 7 of the
vitamin C therapy which was 2.4% and 1.7% respectively conﬁrming
successful therapy with ascorbic acid. Patient is being planned for
splenectomy for deﬁnitive therapy of ITP. Fig. 1
Similarly, we have recently published another case treated suc-
cessfully with ascorbic acid.2 Table 1 brieﬂy describes details of all
the cases plus another case recently reported by Reeves et al.3 In
the case reported by Reeves et al, oncologists gave rasburicase as
an emergency drugwithout knowing G6PD status of patient thereby
leading to methemoglobinemia.3 Basic principle of screening tests
for G6PD deﬁciency is the inability of cells from deﬁcient individuals
to convert an oxidised substrate to a reduced state. Results of this test
is usually available within couple of hours and hence decision of us-
ing oxidising agents like rasburicase should be taken accordingly.
Case of Toker et al is similar to ours in terms of same inciting agent
(Dapsone) and unavailability of methylene blue during initial phase
of therapy thereby relying on other alternative agents like ascorbic
acid and hyperbaric O2 therapy.1 While author could arrangeFig. 1. A. EDTA vial showing chocolate brown colour of patient as compared to fresh
red colour of a control sample. B. Inciting drug- Dapsone that caused
methemoglobinemia.
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Table 1
Recent cases of methemoglobinemia managed with ascorbic acid.
Author Age (Years)/
sex
Race Baseline disease Inciting drug G6PD status MetHb (%) Dose of ascorbic acid used Total dose of
ascorbic
acid used
Tokar et al1 34/M e Lichen Planus Dapsone NA 28.2 2 g  1 dose 2 g
Reeves DJ et al3 46/M African-American Multiple myeloma Rasburicase Deﬁcient 14.5 5 gm q 6 hrly ( 6 doses) 30 g
Deo P et al2 15/M Asian (Indian) Napthalene ball
poisoning
Moth ball Deﬁcient 25.3 0.5 gm q 12 hrly ( 16 doses) 8 g
Present case 45/M Asian (Indian) Immune
thrombocytopenia
Dapsone Negative 18.3 1 gm q 12 hrly ( 14 doses) 14 g
K.K. Sahu et al. / Turkish Journal of Emergency Medicine 16 (2016) 119e120120methylene blue later from neighbouring city, we continued our pa-
tient on ascorbic acid and found good results in both of our cases.1,2
Purpose of writing this letter is to sensitise haematologists and
oncologists regarding the importance of getting G6PD levels in
cases where rasburicase and other similar drugs are planned to
be used. Secondly, successful management of both the cases (pre-
sent case and Toker et al case) suggests ascorbic acid as an alterna-
tive, cheap and easily available drug which can be used either as a
bridging therapy till the time methylene blue could be arranged or
as a sole agent when later is unavailable.
Ethical statement
The article doesn't contain participation of any human being and
animal.
Conﬂict of interest
Authors have no conﬂicts of interest to declare.References
1. Toker I, Yesilaras M, Tur FC, Toktas R. Methemoglobinemia caused by dapsone
overdose: which treatment is best? Turk J Emerg Med. 2016 Mar 9;15:182e184.2. Deo P, Sahu KK, Dhibar DP, Varma SC. Naphthalene ball poisoning: a rare cause of
acquired methemoglobinaemia. BMJ Case Rep. 2016 May;25, 2016.
3. Reeves DJ, Saum LM, Birhiray RIV. Ascorbic acid for treatment of apparent
rasburicase-induced methemoglobinemia in a patient with acute kidney injury
and assumed glucose-6-phosphate dehydrogenase deﬁciency. Am J Health Syst
Pharm. 2016 May 1;73. e238e42.Kamal Kant Sahu, Deba Prasad Dhibar
Department of Internal Medicine, PGIMER, Chandigarh 160012, India
E-mail addresses: everlastingkamal@yahoo.com (K.K. Sahu),
drdeba_prasad@yahoo.co.in (D.P. Dhibar).
Archana Gautam
Department of Internal Medicine, UCMS, New Delhi 110095, India
E-mail address: archana.ucms@gmail.com.
Yogeesh Kumar, Subhash Chander Varma*
Department of Internal Medicine, PGIMER, Chandigarh 160012, India
E-mail address: yogibmcri@gmail.com (Y. Kumar).
* Corresponding author.
E-mail address: suvarma@hotmail.com (S.C. Varma).
30 June 2016
Available online 5 August 2016
